UBS Group’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Sell |
|
|||||
|
2025
Q1 | $16.8K | Sell |
|
|||||
|
2024
Q4 | $30.1K | Buy |
|
|||||
|
2024
Q3 | $19.3K | Sell |
|
|||||
|
2024
Q2 | $38.9K | Sell |
|
|||||
|
2024
Q1 | $163K | Sell |
|
|||||
|
2023
Q4 | $118K | Buy |
|
|||||
|
2023
Q3 | $38.5K | Sell |
|
|||||
|
2023
Q2 | $73.8K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $25.3K | Sell |
|
|||||
|
2022
Q3 | $43K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $1.16M | Buy |
|
|||||
|
2021
Q2 | $96K | Sell |
|
|||||
|
2021
Q1 | $129K | Buy |
|
|||||
|
2020
Q4 | $17K | Buy |
|